首页> 美国卫生研究院文献>Frontiers in Genetics >Comparison of Analysis Tools for miRNA High Throughput Sequencing Using Nerve Crush as a Model
【2h】

Comparison of Analysis Tools for miRNA High Throughput Sequencing Using Nerve Crush as a Model

机译:使用神经粉碎模型作为miRNA高通量测序分析工具的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recent advances in sample preparation and analysis for next generation sequencing have made it possible to profile and discover new miRNAs in a high throughput manner. In the case of neurological disease and injury, these types of experiments have been more limited. Possibly because tissues such as the brain and spinal cord are inaccessible for direct sampling in living patients, and indirect sampling of blood and cerebrospinal fluid are affected by low amounts of RNA. We used a mouse model to examine changes in miRNA expression in response to acute nerve crush. We assayed miRNA from both muscle tissue and blood plasma. We examined how the depth of coverage (the number of mapped reads) changed the number of detectable miRNAs in each sample type. We also found that samples with very low starting amounts of RNA (mouse plasma) made high depth of mature miRNA coverage more difficult to obtain. Each tissue must be assessed independently for the depth of coverage required to adequately power detection of differential expression, weighed against the cost of sequencing that sample to the adequate depth. We explored the changes in total mapped reads and differential expression results generated by three different software packages: miRDeep2, miRNAKey, and miRExpress and two different analysis packages, DESeq and EdgeR. We also examine the accuracy of using miRDeep2 to predict novel miRNAs and subsequently detect them in the samples using qRT-PCR.
机译:样品制备和下一代测序分析的最新进展使得以高通量方式分析和发现新的miRNA成为可能。在神经系统疾病和损伤的情况下,这些类型的实验受到更多限制。可能是因为在活着的患者中无法直接进行脑和脊髓等组织的直接采样,而血液和脑脊液的间接采样会受到少量RNA的影响。我们使用小鼠模型来检查响应急性神经挤压的miRNA表达的变化。我们从肌肉组织和血浆中分析了miRNA。我们检查了覆盖深度(映射读段的数量)如何改变每种样品类型中可检测到的miRNA的数量。我们还发现,具有非常低的RNA起始量(小鼠血浆)的样品使更难获得高深度的成熟miRNA。必须对每个组织的差异深度进行独立评估,以充分检测差异表达,并权衡将样品测序到足够深度的成本。我们探索了由三个不同的软件包(miRDeep2,miRNAKey和miRExpress)以及两个不同的分析软件包(DESeq和EdgeR)生成的总映射读段和差异表达结果的变化。我们还检查了使用miRDeep2预测新型miRNA并随后使用qRT-PCR在样品中检测出它们的准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号